Richmond Club - Page 3 of 13 -


Unhappy With The Performance Of Your Portfolio?

Greg Beckett CIM, FCSI Is The Chartered Investment Manager Who Has Been Picking Stocks For The Richmond Club Index, Causing It To Grow By An Average Of 19.76% Since Inception 15 Years Ago SUBSCRIBE NOW
Richmond Club IndexTSX Venture
S&P 500
Theoretical Richmond
Fund 1% MER
Berkshire Hathaway

Our Upcoming Events

January 29th 2020
  • PyroGenesis Canada Inc. (TSX-V:PYR)
  • NanoVibronix Inc. (Nasdaq:NAOV)
  • Boardwalk Tech (TSX-V:BWLK)
  • RYU Apparel Inc. (TSX-V:RYU)

Avidian Gold: Advanced Exploration Projects in Gold Belts that Produce Multi-million Ounce Deposits

Company: Avidian Gold Chairman, CEO and President: David Anderson Markets: TSXV: AVG Market Cap (09/09/19): 16,296,346 Share Price (08/16/19): $0.20 52-week high/low: $0.68/$0.09 Sector: Mining Avidian Gold (“Avidian”) is an advanced stage exploration company with two gold projects in Alaska and a gold-copper project in Nevada. Avidian’s experienced board and management team has a track record of creating wealth for shareholders by […]
Read more

September 20 Newsletter

GENERATION MINING COMPLETES TRANSFORMATION TRANSACTION ACQUIRING MARATHON PALLADIUM PROJECT FROM MINING MAJOR With five properties across some of Canada’s most coveted mining jurisdictions, Generation Mining Limited is a mineral exploration and development company with a unique proposition for potential investors. Read now MPX INTERNATIONAL: GLOBAL CANNABIS COMPANY PROJECTS STRONG REVENUE AND EBITDA GROWTH IN 2020 MPX […]
Read more

October 9 Newsletter

LEXARIA BIOSCIENCE: A DRUG DELIVERY SYSTEM THAT IS DISRUPTING THE BIOTECH SECTOR  With more than 60 patents pending in over 40 countries and 15 patents granted in the U.S. and Australia for its DehydraTECH™ delivery technology, Lexaria is emerging as a global leader in orally administered products. The Canadian biotech company is developing healthy, effective ways […]
Read more

Lexaria Bioscience: A Drug Delivery System that’s Disrupting the Biotech Sector

Company: Lexaria Bioscience Corp. Chairman, CEO and President: Chris Bunka Markets: CSE: LXX, OTCQX: LXRP Sector: Biotechnology Lexaria Bioscience Corp. (Lexaria) is a Canadian biotech company that’s developing healthy, effective ways to deliver drugs that treat a variety of illnesses. The company has four wholly-owned subsidiary companies, each dedicated to operating in a specific industry – nicotine, pharmaceuticals, hemp […]
Read more